Acquisition of host cell-surface-derived molecules by HIV-1

AIDS

Volumn 10, Issue 14, 1996, Pages 1611-1620

  Frank, Ines ^a   Stoiber, Heribert ^a   Godar, Samuel ^b   Stockinger, Hannes ^b   Steindl, Franz ^b   Katinger, Hermann W D ^b   Dierich, Manfred P ^a,c  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Institut für Hygiene und Sozialmedizin   (Austria)

Author keywords

Adhesion molecules; Glycophosphatidylinositol anchored proteins; HIV 1; HIV 1 envelope; Membrane composition

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL;

ARTICLE; CELL SURFACE; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRION; VIRUS CELL INTERACTION;

EID: 0029853890     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199612000-00004     Document Type: Article

References (47)

1. Arthur LO, Bess JW, Sowder RC, et al.: Cellular proteins bound to immunodeficiency viruses: implication for pathogenesis and vaccines. Science 1992, 258:1935-1938.
2. Marshang P, Sodroski J, Würzner R, Dierich MP: Decayaccelerating factor protects human HIV-1 from inactivation by human complement. Eur J Immunol 1995, 25:285-290.
3. Guo MML, Hildreth JEK: HIV acquires functional adhesion receptors from host cells. AIDS Res Hum Retroviruses 1995, 11:1007-1013.
4. Griffiths G, Rottier P: Cell biology of viruses that assemble along the biosynthetic pathway. Semin Cell Biol 1992, 3:367-381.
5. Fields B, Knipe D (Eds): Virology Vol 1,2; 1996.
6. Dahlberg JE, Gaskin JM, Perk K: Morphological and immunological comparison of caprine arthritis encephalitis and ovine progressive pneumonia viruses. J Virol 1981, 39:914-919.
7. Crawford TB, Adams SD, Cheevers WP, Cork LC: Chronic arthritis in goats caused by a retrovirus. Science 1980, 207:997-999.
8. Gonda MA, Charman HP, Walker JL, Coggins: Scanning and transmission electron microscopic study of equine infectious anemia virus. Am J Vet Res 1978, 39:731-740.
9. Schiedlovsky G: Structure of RNA tumor viruses. In Recent Advances in Cancer Research: Cell Biology, Molecular Biology, and Tumor Virology, Vol. 1. Edited by Gallo RC. Boca Raton: CRC Press; 1985:189-245.
10. Gartner S, Markovits P, Markovits M, Kaplan MH, Gallo RC, Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986, 233:215-219.
11. Gendelman HE, Orenstein JM, Martin MA, et al.: Efficient isolation and propagation of human immunodeficiency virus on rCSF-1 treated monocytes. J Exp Med 1988, 167:1428-1441.
12. Nicholson JKA, Cross GD, Callaway CS, McDougal JS: In vitro infection of human monocytes with human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol 1986, 137:323-329.
13. Orenstein JM, Meltzer MS, Phipps T, Gendelman HE: Cytoplasmic assembly and accumulation of human immunodeficiency virus type 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J Virol 1988, 62:2478-2586.
14. Saifuddin M, Parker CJ, Peeples ME, et al.: Role of virionassociated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J Exp Med 1995, 182:501-509.
15. Saifuddin M, Ghassemi M, Patki C, Parker CJ, Spear GT: Host cell components affect the sensitivity of HIV-1 to complement-mediated virolysis. AIDS Res Hum Retroviruses 1994, 10:829-837.
16. Uciechowski P, Schmidt H: Cluster report: CD11. In Leukocyte Typing IV: White Cell Differentiation Antigen. Edited by Knapp W, Dorken B, Gilks W, Schmidt R, Stein H, Von dem Borne A. Oxford: Oxford University Press: 1989;543-551.
17. Diamond MS, Garcia-Aguilar JK, Bickford JK, Corbi AL, Springer TAJ: The I-domain is a major recognition site on leukocyte integrin Mac-1 (CD11a/CD18) for four distinct adhesion ligands. Cell Biol 1993, 120:1031-1043.
18. Messika EJ, Avni O, Gallily R, Yefenof E, Barniash M: Identification and characterization of a novel protein associated with macrophage complement receptor 3. J Immunol 1995, 154:6563.
19. Ebenbichler CF, Röder C, Vornhagen R, Ratner L, Dierich MP: Cell surface proteins binding to recombinant soluble HIV-1 and HIV-2 transmembrane proteins. AIDS 1993, 7:489-495.
20. Muster T, Steindl F, Purtscher M, et al.: A conserved neutralizing epitope of human immunodeficiency virus type 1. J Virology 1993, 67:6642-6647.
21. Trokla A, Purtscher M, Muster T, et al.: Human monoclonal mAb 2G12 defines a distinctive neutralization epitope on the gp120 gp of human immunodeficiency virus type 1. J Virol 1996, 70:1100-1108.
22. Ratner L, Haseltine W, Patarca R, et al.: Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985, 313:277-284.
23. Purtscher M, Trkola A, Gruber G, et al.: A broadly neutralizing human monoclonal mAb against gp41 of human HIV-1. AIDS Res Hum Retroviruses 1994, 10:1651-1658.
24. Larcher C, Schultz TF, Hofbauer J, et al.: Expression of the C3d/EBV receptor and of other cell membrane surface markers is altered upon HIV-1 infection of myeloid, T- and B-cells. J Acquir Immune Defic Syndr 1990, 3:103-108.
25. Fais S, Capobianchi MR, Abbate I, et al.: Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix protein. AIDS 1995, 9:329-335.
26. Cantin R, Fortin JF, Tremblay M: The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. Virology 1996, 218, 372-381.
27. Abbate I, Capobianci MR, Fais S, et al.: Host cell antigenetic profile acquired by HIV-1 is a marker of its cellular origin. Arch Virol 1995, 140:1849-1854.
28. gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into virus-like particles. J Virol 1990, 64:2743-2750.
29. gag virus-like particles from recombinant baculovirus infected insect cells. Cell 1989, 59:103-112.
30. Shields A, Witte ON, Rothenberg E, Baltimore D: High frequency of aberrant expression of Moloney murine leukemia virus in clonal infections. Cell 1978, 14:601-609.
31. Owens RJ, Dubay JW, Hunter E, Compans RW: Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl Acad Sci USA 1991, 88:3987-3991.
32. Owens RJ, Compans RW: Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J Virol 1989, 63:978-982.
33. Lodge R, Göttlinger H, Gabuzda D, Cohen EA, Lemay G: The intracytoplasmatic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol 1994, 68:4857-4861.
34. Yu X, Yuan X, Matsuda Z, Lee TH, Essex M: The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol 1992, 66:4966-4971.
35. Facke M, Janetzko A, Shoeman RL, Kraeusslich HG: A large deletion in the matrix domain of the human immunodeficiency virus particle assembly from the plasma membrane to the endoplasmatic reticulum. J Virol 1993, 67:4972-4980.
36. Kraeusslich HG, Ochsenbauer C, Traenckner AM, et al.: Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env products with or without active HIV proteinase. Virology 1993, 192:605-617.
37. Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, Garten W: Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 1992, 360:358-361.
38. 2-integrins and Src-kinases within a single receptor complex of human monocytes. J Exp Med 1995, 181:1381-1390.
39. Kindzelskii AL, Laska ZO, Todd RF, Petty HR: Urokinase plasminogen activator receptor reversibly dissociates from complement receptor type 3 (CD11b/CD18) during neutrophil polarization. J Immunol 1996, 156:297-309.
40. Stoiber H, Pinter C, Siccardi G, Alberto C, Dierich MP: Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J Exp Med 1996, 183:307-310.
41. Dierich MP, Stoiber H, Clivio A: A 'complementary' AIDS vaccine. Nature Med 1996, 2:153-155.
42. Thieblemont N, Haeffner-Cavaillon N, Haeffner A, Cholley B, Weiss L, Kazatchkine MD: Triggering of complement receptors CR1 (CD35) and CR3 (CD11a/CD18) induces nuclear translocation of NF-κB (p50/65) in human monocytes and enhances viral replication in HIV-1 infected monocytic cell. J Immunol 1995, 155:4861-4867.
43. Matsuyama T, Kobayashi N, Yamamoto N: Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991, 5:1405-1417.
44. Clark BD, Collins KL, Gandy MS, Webb AC, Auron PE: Genomic sequence for human prointerleukin 1 beta: possible evolution from a reverse-transcribed prointerleukin 1 alpha gene. Nucleic Acids Res 1986, 14:7897-7914.
45. Jongeneel CV: The TNF and lymphotoxin promotors. In Tumor Necrosis Factors: the Molecules and their Emerging Role in Medicine. Edited by Beutler B. New York: Raven Press; 1992:539.
46. Yurochko AD, Liu DY Eierman D, Haskill S: Integrins as a signal transduction molecule regulating monocyte immediate-early gene induction. Prof Natl Acad Sci USA 1992, 89:9034-9038.
47. Chen YH, Böck G, Vornhagen R, Steindl F, Katinger H, Dierich M: HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and class II expression by gp41. Mol Immunol 1994, 31:977-982.